PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
G. pentaphyllum was comparable to n-3 fatty acids and red yeast rice in normalizing serum lipids; combined with n-3 fatty acids, it was superior in normalizing triglycerides and total cholesterol [PMID:36091752].
Meta-analysis indicates G. pentaphyllum effectively reduces triglyceride levels and increases high-density lipoprotein cholesterol [PMID:37129524].
In vitro and in vivo tests indicate anti-cancer activities, with specific gypenosides showing antiproliferative effects against human tumor cell lines including A549, HepG2, MCF7, and HL-60 [PMID:34684830, PMID:30965662, PMID:20382401, PMID:21279881].
Possesses hypoglycemic properties [PMID:34684830] and exhibits anti-hyperglycemic effects in obese mice when used in combination extracts [PMID:41011571].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 34684830 (2021) — Progress in the Medicinal Value, Bioactive Compounds, and Pharmacological Activities of Gynostemma pentaphyllum. · Molecules (Basel, Switzerland)
- 2.PMID: 37829299 (2023) — Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs. · Frontiers in pharmacology
- 3.PMID: 28662582 (2017) — Further New Gypenosides from Jiaogulan (Gynostemma pentaphyllum). · Journal of agricultural and food chemistry
- 4.PMID: 35282005 (2022) — Prebiotic properties of jiaogulan in the context of gut microbiome. · Food science & nutrition
- 5.PMID: 27708693 (2016) — Anti-cancer effects of Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan).